Abstract:Background Systemic lupus erythematosus (SLE) is a chronic and systemic autoimmune disease, which is accompanied by abnormal activation of T/B lymphocytes, multiple autoantibodies and immune complex deposition. Granzyme B producing (GrB+) B cells are a group of new regulatory B cell subsets, which can participate in the pathogenesis of autoimmune disease, but its role in SLE is not clear. In this study, we investigate the expression level of Granzyme B producing B cells in SLE patients and lupus-like mouse models. Methods 1. Patients with SLE (n=7) meeting 1997 American College of Rheumatology revised criteria were enrolled from the Department of Rheumatology and Immunology. 15 healthy individual samples were obtained from physical examination center in our hospital. We collected 4 mL peripheral anticoagulant blood from both groups and peripheral blood mononuclear cells were isolated. The proportion of GrB +B cells in PBMC was identified by flow cytometry. 2. A lupus-like mouse model induced by transfer of spleen cells from bm12 mice was constructed. Two wildtype C57BL/c mice and two lupus-like mouse models (both 68 weeks old mice) were sacrificed by CO2anesthesia. The spleens of the mice were aseptically isolated, and the spleen single cells were obtained after grinding the tissues. The ratio of GrB +Breg cells in the spleen cells of the two groups was detected by flow cytometry (FACS). 3. SPSS24.0 software was used for statistical analysis, and p<0.05 was considered statistically significant Results 1. Using flow cytometry 7AAD label excludes dead cells, CD3 marker excludes T lymphocytes and CD56 markers exclude NK cells. After CD14 labeling excludes monocytes/macrophages, the proportion of GrB +Breg cells in peripheral blood of healthy controls was 7.52%; Compared with healthy controls, the proportion of GrB +Breg cells in peripheral blood of SLE patients (4.45%) showed a significant downward trend. 2. Compared with the wild type control mice, the proportion of GrB +Breg cells in the spleen cells of lupus mouse model (2.14%) showed a significant downward trend. Conclusions The proportion of GrB +Breg cells in the peripheral blood of SLE patients and the spleen cells of lupus-like mouse models showed a downward trend, which may be related to the pathogenesis of SLE, but the exact role remains to be further verified. Funding Source(s): This study was supported by grants from the National Natural Science Foundation of China.

Upregulation of Granzyme B and C-X3-C Motif Receptor 1 in Circulating Plasmablasts Was Negatively Regulated by Notch Signal in Patients with Systemic Lupus Erythematosus.

Aberrant T Cell Subsets and Cytokines Expression Profile in Systemic Lupus Erythematosus.

Dysregulated T Cell Activation and Aberrant Cytokine Expression Profile in Systemic Lupus Erythematosus.

Abnormal Expression of Cd43 in Patients with Systemic Lupus Erythematosus and Its Clinical Significance

Impaired Granzyme B-producing Regulatory B Cells in Systemic Lupus Erythematosus

LncRNA XIST Alters the Balance of Peripheral Blood Immune Cells in Systemic Lupus Erythematosus by Regulating the miR-17-92/OFLM4 and CEACAM8 Axis

lncRNA X-inactive-specific transcript is a potential biomarker related to changes in CD4 + T cell levels in systemic lupus erythematosus

Upregulation of CX3CR1 expression in circulating T cells of systemic lupus erythematosus patients as a reflection of autoimmune status through characterization of cytotoxic capacity

118 Granzyme B Producing B Cells in Systemic Lupus Erythematosus Patients and Lupus-Like Mouse Models

Impaired regulatory function of granzyme B-producing B cells against T cell inflammatory responses in lupus mice

Abnormal lower expression of GPR183 in peripheral blood T and B cell subsets of systemic lupus erythematosus patients

Contribution and underlying mechanisms of CXCR4 overexpression in patients with systemic lupus erythematosus

Elevated Apoptosis and Impaired Proliferation Contribute to Downregulated PeripheralγδT Cells in Patients with Systemic Lupus Erythematosus

Expression of chemokine receptors CX3CR1 mRNA in patients with systemic lupus erythematosus

Expressions of BAFF/BAFF Receptors and Their Correlation with Disease Activity in Chinese SLE Patients

Circulating CD8 + LGALS9 + T Cell Population Exhibiting Low Cytotoxic Characteristics are Decreased in Patients with Systemic Lupus Erythematosus

CXCR3 deficiency decreases autoantibody production by inhibiting aberrant activated T follicular helper cells and B cells in lupus mice

SIT1 Identifies Circulating Hypoactive T Cells with Elevated Cytotoxic Molecule Secretion in Systemic Lupus Erythematosus Patients

RasGRP3 in peripheral blood mononuclear cells is associated with disease activity and implicated in the development of systemic lupus erythematosus.

Upregulated Bclg(L) Expression Enhances Apoptosis of Peripheral Blood Cd4(+) T Lymphocytes in Patients with Systemic Lupus Erythematosus

Expression of systemic lupus erythematosus PBLCR1